{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:47:50Z","timestamp":1761745670868,"version":"build-2065373602"},"reference-count":44,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Neuropathic pain (NP) in head and neck cancer (HNC) patients represents a treatment challenge. Most studies investigating drugs against NP are conducted in patients suffering with diabetic neuropathy or postherpetic neuralgia, while data are limited in cancer pain management. Additionally, regarding cancer therapy-related NP, most of the studies do not focus on HNC patients. The aim of this review is to identify the studies on systematically administered medication for NP management that included HNC patients under radiotherapy. Methods: A systematic literature search was performed, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, in PubMed, Cochrane Library, Web of Science and ClinicalTrials.gov on 30 October 2021. The medical subject heading (MeSH) terms were (\u201chead and neck cancer\u201d OR \u201ctumor\u201d) AND \u201cneuropathic pain\u201d AND \u201cmedication\u201d AND \u201cradiotherapy.\u201d The Cochrane Collaboration tool was used for quality assessment. Results: The search identified 432 articles. Three more articles were identified after searching the reference lists of the retrieved articles. A total of 10 articles met the eligibility inclusion criteria and were included in this review; 6 on gabapentin, 1 on pregabalin, 1 on nortriptyline, 1 on methadone, and 1 on ketamine. Statistically significant results in pain reduction compared to placebo or standard pain medication were found in the studies on pregabalin (p = 0.003), methadone (p = 0.03), ketamine (p = 0.012), and in two out of six gabapentin studies (p &lt; 0.004). Two of the studies (both concerning gabapentin) had no comparison arm. Conclusions: Treatments including pregabalin, methadone, ketamine, and gabapentin were found to provide pain relief against HNC NP. While there is a plethora of pharmacological treatments available for the management of NP, only a few studies have been conducted regarding the pharmacological management of therapy-related NP in HNC patients. More studies should be conducted regarding the pharmacological approaches in HNC therapy-related NP so that specific treatment algorithms can be developed.<\/jats:p>","DOI":"10.3390\/jcm11164877","type":"journal-article","created":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T23:51:01Z","timestamp":1661125861000},"page":"4877","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pharmacological Management of Neuropathic Pain after Radiotherapy in Head and Neck Cancer Patients: A Systematic Review"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0009-4911","authenticated-orcid":false,"given":"Maria","family":"Kouri","sequence":"first","affiliation":[{"name":"A\u2019 Anesthesiology Clinic, Pain Management and Palliative Care Center, Aretaieio University Hospital, Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece"},{"name":"Dental Oncology Unit, Department of Oral Medicine and Pathology and Hospital Dentistry, Dental School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7671-4056","authenticated-orcid":false,"given":"Martina","family":"Rekatsina","sequence":"additional","affiliation":[{"name":"Department of Anesthesia Pain Therapy and Palliative Care, Aretaieio University Hospital, Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athina","family":"Vadalouca","sequence":"additional","affiliation":[{"name":"Pain Clinic, Athens Medical Center, 15125 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioanna","family":"Siafaka","sequence":"additional","affiliation":[{"name":"A\u2019 Anesthesiology Clinic, Pain Management and Palliative Care Center, Aretaieio University Hospital, Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouil","family":"Vardas","sequence":"additional","affiliation":[{"name":"Dental Oncology Unit, Department of Oral Medicine and Pathology and Hospital Dentistry, Dental School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erofili","family":"Papadopoulou","sequence":"additional","affiliation":[{"name":"Dental Oncology Unit, Department of Oral Medicine and Pathology and Hospital Dentistry, Dental School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Paladini","sequence":"additional","affiliation":[{"name":"Department of MESVA, University of L\u2019Aquila, 67100 L\u2019Aquila, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3822-2923","authenticated-orcid":false,"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[{"name":"Paolo Procacci Foundation, 00193 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"key":"ref_1","unstructured":"International Association for the Study of Pain (2022, July 20). IASP Taxonomy. Pain Terms. Neuropathic Pain. Available online: www.iasp-pain.org\/Taxonomy#Neuropathicpain."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Farah, C., Balasubramaniam, R., and McCullough, M. (2019). Orofacial Pain in Patients with Cancer and Mucosal Diseases. Contemporary Oral Medicine, Springer.","DOI":"10.1007\/978-3-319-72303-7"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1533-2500.2006.00054.x","article-title":"Epidemiology of refractory neuropathic pain","volume":"6","author":"Taylor","year":"2006","journal-title":"Pain Pract."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2478\/fco-2019-0016","article-title":"Oral complications of head and neck cancer therapy","volume":"12","author":"Kouri","year":"2021","journal-title":"Forum Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1533-2500.2011.00485.x","article-title":"Pharmacological Treatment of Neuropathic Cancer Pain: A Comprehensive Review of the Current Literature","volume":"12","author":"Vadalouca","year":"2012","journal-title":"Pain Pract."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2174\/1874079001104010007","article-title":"Oral Mucositis, Pain and Xerostomia in 135 Head and Neck Cancer Patients Receiving Radiotherapy with or without Chemotherapy","volume":"4","author":"Kouloulias","year":"2011","journal-title":"Open Cancer J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.critrevonc.2015.11.010","article-title":"Pain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendations","volume":"99","author":"Mirabile","year":"2016","journal-title":"Crit Rev. Oncol\/Hematol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.critrevonc.2017.05.012","article-title":"The vicious circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity","volume":"116","author":"Bossi","year":"2017","journal-title":"Crit Rev. Oncol\/Hematol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.radonc.2010.08.003","article-title":"A prospective, randomized, multi-center trial to investigate Actovegin in prevention and treatment of acute oral mucositis caused by chemoradiotherapy for nasopharyngeal carcinoma","volume":"97","author":"Wu","year":"2010","journal-title":"Radiother. Oncol."},{"key":"ref_10","first-page":"2010","article-title":"Oral mucositis\u2013related neuropathic pain in head and neck cancer patients receiving radiotherapy or chemo-radiotherapy. A prospective study","volume":"26","author":"Kouri","year":"2021","journal-title":"J. Buon."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00520-006-0171-1","article-title":"Comparing pain control and ability to eat and drink with standard therapy vs. Gelclair: A preliminary, double centre, randomized controlled trial on patients with radiotherapy-induced oral mucositis","volume":"15","author":"Barber","year":"2007","journal-title":"Support Care Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0360-3016(99)00402-2","article-title":"Oral glutamine to alleviate radiation-induced oral mucositis: A pilot randomized trial","volume":"46","author":"Huang","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1758-3284-1-26","article-title":"Neuropathic and nociceptive pain in head and neck cancer patients receiving radiation therapy","volume":"1","author":"Epstein","year":"2009","journal-title":"Head Neck Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/annonc\/mds233","article-title":"Management of cancer pain: ESMO clinical practice guidelines","volume":"23","author":"Ripamonti","year":"2012","journal-title":"Ann. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1177\/0022034514540174","article-title":"Review of Preclinical studies on treatment of Mucositis and Associated Pain","volume":"93","author":"Viet","year":"2014","journal-title":"J. Dent. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/014107680309600804","article-title":"Identifying neuropat.hic pain in patients with head and neck cancer: Use of the Leeds Assessment of Neuropathic Symptoms and Signs Scale","volume":"96","author":"Potter","year":"2003","journal-title":"J. R. Soc. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1185\/03007995.2011.614934","article-title":"Mechanisms of pain transmission and pharmacologic management","volume":"27","author":"Argoff","year":"2011","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0885-3924(01)00420-1","article-title":"Problems recruiting cancer patients to a comparative clinical trial of drug treatments for neuropathic pain in palliative care","volume":"23","author":"Sinnott","year":"2002","journal-title":"J. Pain Symptom Manag."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3109\/0284186X.2016.1167958","article-title":"Pain following cancer treatment: Guidelines for the clinical classification of predominant neuropathic, nociceptive and central sensitization pain","volume":"55","author":"Nijs","year":"2016","journal-title":"Acta Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: A systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40122-020-00210-3","article-title":"Pharmacological Management of Painful Peripheral Neuropathies: A Systematic Review","volume":"10","author":"Liampas","year":"2021","journal-title":"Pain Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.17763\/haer.41.4.437714870334w144","article-title":"Accumulating Evidence: Procedures for Resolving Contradictions among Different Research Studies","volume":"41","author":"Light","year":"1971","journal-title":"Harv. Educ. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/cncr.32676","article-title":"A single-institution, randomized, pilot study evaluating the efficacy of gabapentin and methadone for patients undergoing chemoradiation for head and neck squamous cell cancer","volume":"126","author":"Hermann","year":"2020","journal-title":"Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1002\/hed.26407","article-title":"Preventive use of gabapentin to decrease pain and systemic symptoms in patients with head and neck cancer undergoing chemoradiation","volume":"42","author":"Smith","year":"2020","journal-title":"Head Neck"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.anl.2016.02.012","article-title":"Randomized trial of standard pain control with or without gabapentin for pain related to radiation-induced mucositis in head and neck cancer","volume":"43","author":"Kataoka","year":"2016","journal-title":"Auris Nasus Larynx"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1200\/JCO.18.00896","article-title":"Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients with Head and Neck Cancer: A Randomized Controlled Trial","volume":"37","author":"Jiang","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejca.2016.06.025","article-title":"Methadone is superior to fentanyl in treating neuropathic pain in patients with head-and-neck cancer","volume":"65","author":"Haumann","year":"2016","journal-title":"Eur. J. Cancer."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1002\/cncr.25274","article-title":"Gabapentin for the treatment of pain syndrome related to radiation-induced mucositis in patients with head and neck cancer treated with concurrent chemoradiotherapy","volume":"116","author":"Weinstein","year":"2010","journal-title":"Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hed.21165","article-title":"Gabapentin for the treatment of pain related to radiation-induced mucositis in patients with head and neck tumors treated with intensity-modulated radiation therapy","volume":"32","author":"Weinstein","year":"2010","journal-title":"Head Neck"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/02841860152619179","article-title":"Randomized trial of opioids versus tricyclic antidepressants for radiation-induced mucositis pain in head and neck cancer","volume":"40","author":"Ehrnrooth","year":"2001","journal-title":"Acta Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00455-014-9521-1","article-title":"Effect of gabapentin on swallowing during and after chemoradiation for oropharyngeal squamous cell cancer","volume":"29","author":"Starmer","year":"2014","journal-title":"Dysphagia"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0885-3924(01)00373-6","article-title":"Oral ketamine as an adjuvant to oral morphine for neuropathic pain in cancer patients","volume":"23","author":"Kannan","year":"2002","journal-title":"J. Pain Symptom Manag."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1007\/s12325-020-01462-3","article-title":"Non-Pharmacological Management of Painful Peripheral Neuropathies: A Systematic Review","volume":"37","author":"Liampas","year":"2020","journal-title":"Adv Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2147\/JPR.S341378","article-title":"Peripheral neuropathic pain following breast cancer: Effectiveness and tolerability of high-concentration capsaicin patch","volume":"15","author":"Dupoiron","year":"2022","journal-title":"J. Pain Res."},{"key":"ref_38","first-page":"CD007076","article-title":"Pregabalin for neuropathic pain in adults","volume":"1","author":"Derry","year":"2019","journal-title":"Cochrane Database Syst Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e100178","DOI":"10.5812\/aapm.100178","article-title":"Ketamine as adjuvant for acute pain management","volume":"9","author":"Imani","year":"2019","journal-title":"Anesth. Pain Med."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Israel, J.E., St Pierre, S., Ellis, E., Hanukaai, J.S., Noor, N., Varrassi, G., Wells, M., and Kaye, A.D. (2021). Ketamine for the treatment of chronic pain: A comprehensive review. Health Psychol Res., 9.","DOI":"10.52965\/001c.25535"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1097\/00002508-200006001-00013","article-title":"The use of NMDA-receptor antagonists in the treatment of chronic pain","volume":"16","author":"Hewitt","year":"2000","journal-title":"Clin. J. Pain."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/pm\/pnaa044","article-title":"Effectiveness of Adjunctive Analgesics in Head and Neck Cancer Patients Receiving Curative (Chemo-) Radiotherapy: A Systematic Review","volume":"22","author":"Lefebvre","year":"2021","journal-title":"Pain Med."},{"key":"ref_43","unstructured":"(2022, July 25). A Pilot Study at a Single-Institution of Pregabalin in the Management of Mucositis Pain in Patients Undergoing Chemoradiation Therapy to the Head and Neck, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT02277548?term=pain+medication&recrs=e&rslt=With&cond=head+and+neck+cancer&draw=3&rank=19."},{"key":"ref_44","unstructured":"Spera, M.C., Cesta, M.C., Zippoli, M., Varrassi, G., and Allegretti, M. (Pain Ther., 2022). Therapeutic potential of C5aR inhibitors in CIPN treatment: Targeting the C5a\/C5aR axis, Pain Ther., submitted."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/16\/4877\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:12:33Z","timestamp":1760141553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/16\/4877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":44,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["jcm11164877"],"URL":"https:\/\/doi.org\/10.3390\/jcm11164877","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2022,8,19]]}}}